Stock Events

Stock Events

Currenc Group 

$3.51
19
-$0.34-8.83% Friday 20:00
+$0.14+3.99%Friday 23:30After hours

Statistics

Day High
3.66
Day Low
3.52
52W High
4.73
52W Low
1.312
Volume
14,091
Avg. Volume
-
Mkt Cap
394.11M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

27NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
Next
-0.13
-0.07
-0.01
0.05
Expected EPS
N/A
Actual EPS
N/A

Financials

-85.01%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
46.44MRevenue
-39.48MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CURR. It's not an investment recommendation.
NVIDIA
6
NVDA
Intel
5
INTC
Tesla
4
TSLA
Netflix
4
NFLX

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences is a biopharmaceutical company that develops and markets drugs in similar therapeutic areas as Avenir, making them direct competitors in the healthcare market.
AMGEN
AMGN
Mkt Cap224.63B
Amgen is a biotech firm focusing on novel therapies, including treatments for conditions that Avenir Wellness Solutions also targets.
Pfizer
PFE
Mkt Cap152.69B
Pfizer is a large pharmaceutical company with a diverse product portfolio that includes medications in direct competition with those of Avenir Wellness Solutions.
Merck
MRK
Mkt Cap335.14B
Merck operates globally in pharmaceuticals, including areas like immunotherapy and oncology, competing with Avenir's product lines.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie offers a range of biopharmaceuticals that directly compete with Avenir Wellness Solutions in multiple therapeutic areas.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol-Myers Squibb, with its broad range of pharmaceutical products, competes in the same market segments as Avenir Wellness Solutions.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly and Company produces medicines in areas such as mental health and diabetes, overlapping with Avenir's market interests.
Novartis
NVS
Mkt Cap286.78B
Novartis is a global healthcare company that produces drugs that directly compete with Avenir Wellness Solutions' offerings.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson has a large portfolio of pharmaceuticals that includes competitive products in the wellness and therapeutic sectors targeted by Avenir.
Regeneron Pharmaceuticals
REGN
Mkt Cap82.72B
Regeneron Pharmaceuticals specializes in biopharmaceuticals, particularly in areas like immunology and oncology, which are key focus areas for Avenir Wellness Solutions.

About

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It operates into two reportable segments, which are remittance services and sales of airtime, of which maximum revenue is generated from the Remittance segment. Geographically, the group generates the majority of its geographic revenue from Malaysia.
Show more...
CEO
King Ong Kong
Employees
293
Country
Singapore
ISIN
KYG478621009

Listings

COINMARKETCAP
CRYPTO
CURR.CRYPTO
OTC Link
US
AVRW
XNAS
US
CURR

0 Comments

Share your thoughts

FAQ

What is Currenc Group stock price today?▼
The current price of CURR is $3.51 USD — it has decreased by -8.83% in the past 24 hours. Watch Currenc Group stock price performance more closely on the chart.
What is Currenc Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Currenc Group stocks are traded under the ticker CURR.
Is Currenc Group stock price growing?▼
CURR stock has fallen by -3.31% compared to the previous week, the month change is a +5.09% rise, over the last year Currenc Group has showed a +95% increase.
What is Currenc Group market cap?▼
Today Currenc Group has the market capitalization of 394.11M
When is the next Currenc Group earnings date?▼
Currenc Group is going to release the next earnings report on August 24, 2026.
What is Currenc Group revenue for the last year?▼
Currenc Group revenue for the last year amounts to 46.44M USD.
What is Currenc Group net income for the last year?▼
CURR net income for the last year is -39.48M USD.
How many employees does Currenc Group have?▼
As of August 23, 2026, the company has 293 employees.
In which sector is Currenc Group located?▼
Currenc Group operates in the Finance & Payments sector.
When did Currenc Group complete a stock split?▼
The last stock split for Currenc Group was on July 21, 2016 with a ratio of 3.6:1.
Where is Currenc Group headquartered?▼
Currenc Group is headquartered in NEW YORK, Singapore.